SYNTHESIS AND PROPERTIES OF DIAMINEPLATINUM(II) AND DIAMINEPLATINUM(IV) COMPLEXES INVOLVING CYCLOHEXYLIDENEMALONATE LIGAND
- Authors
- JUNG, CS; LEE, SS; KIM, KM; JUNG, OS; SOHN, YS
- Issue Date
- 1995-10-20
- Publisher
- KOREAN CHEMICAL SOC
- Citation
- BULLETIN OF THE KOREAN CHEMICAL SOCIETY, v.16, no.10, pp.981 - 984
- Abstract
- New diamineplatinum(II) complexes of cyclohexylidenemalonate (chm) ligand, A(2)Pt(OOC)(2)C=C(CH2)(4)CH2 (1, A(2)=ethylenediamine (en); 2, A(2)=propylenediamine (pn); 3, A=NH3; 4, A=isopropylamine (ipa)) have been prepared. Their oxidation with H2O2 has led to the corresponding dihydroxoplatinum(IV) complexes: cis, cis, trans-A(2)Pt((OOC)2C=C (CH2)(4)CH2)(OH)(2) (5, A(2)=en; 6, A(2)=pn; 7, A=NH3; 8, A=ipa). The title complexes have been characterized by means of various spectroscopies and X-ray crystallography. 5 crystallizes in the monoclinic space group P2(1)/a (Z 4) with a=12.098(7) Angstrom, b=9.552(2) Angstrom, c 16.258(4) Angstrom, beta=98.03(5)degrees and V=1860(1) Angstrom.(3) The structure was refined to R=0.074. The local geometry around platinum atom is approximately octahedral with each hydroxide group in trans position. These platinum complexes are stable in aqueous solution. Pt(IV) complexes are readily reduced to the corresponding Pt(II) complexes by ascorbic acid.
- Keywords
- PLATINUM ANTICANCER DRUG; DNA; TETRAPLATIN; METABOLITE; REDUCTION; PRODUCTS; CRYSTAL; PLATINUM ANTICANCER DRUG; DNA; TETRAPLATIN; METABOLITE; REDUCTION; PRODUCTS; CRYSTAL
- ISSN
- 0253-2964
- URI
- https://pubs.kist.re.kr/handle/201004/144949
- Appears in Collections:
- KIST Article > Others
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.